Location：Home/News/Company NewsDuring the European Society for Medical Oncology (ESMO) meeting held from October 20 to 24, 2023, in
On September 27, 2023, Tianjin Municipal Bureau of Science and Technology arranged for a panel of ex
On the afternoon of September 25, 2023, Zhangjiang Life Science International Innovation Summit took
KeChow Pharma announced the release of efficacy and safety data for its MEK inhibitor, Tunlametinib,
The 2023 CSCO Guidelines Conference, co-hosted by the Chinese Society of Clinical Oncology and the B
On April 4, 2023, the Center for Drug Evaluation of the National Medical Products Administration app
